# ARNA Pharma Pty., Ltd. – FDA Inspection, May 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/arna-pharma-pty-ltd/f801236b-b289-486d-a01b-07ea4fe53d46
Source feed: FDA_Inspections

> FDA inspection 1089805 of ARNA Pharma Pty., Ltd., May 17, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089805
- Company Name: ARNA Pharma Pty., Ltd.
- Inspection Date: 2019-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1288492 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/arna-pharma-pty-ltd/9b8d027e-c374-4b0f-ab14-c27618e3b54f)
- FDA Inspection 1069444 - 2018-08-03
- FDA Inspection 804043 - 2012-09-21
- FDA Inspection 623897 - 2009-10-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/arna-pharma-pty-ltd/e06145c8-ecf7-4bc1-9e0d-5aab8615b08f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
